Results of peripheral endovascular procedures in the operating room  by Gross, Gary M. et al.
Results of peripheral endovascular procedures 
in the operating room 
Gary M. Gross, MD, Ronny C. Johnson, MD, and Rick M. Roberts, MD, 
Huntsville, Ala. 
Purpose: This study presents the results of closed (percutaneous) and open endovascular 
procedures performed exclusively by vascular surgeons in the operating room and 
compares them with results from combined series from the literature, including primarily 
closed procedures in radiology or cardiology facilities. 
Methods: Retrospective r view of 607 consecutive peripheral arterial and venous angio- 
plasties, stents, thrombolytic cases, and inferior vena caval filters in 446 patients was 
analyzed for immediate success rate, complication rate, and 1-year life table patency rate. 
Results: The incidence of initial technical success was: aorta, 89%; iliac artery, 91%; 
superficial femoral artery, 90%; popliteal artery, 91%; tibial arteries, 79%; arm arteries and 
veins, 86%; renal arteries, 100%; IVC filters, 98%; and iliofemoral veins, 100%. The 1-year 
primary patency rates, including technical failures, were 70.3% in 113 femoropopliteal 
procedures and 83.7% in 194 iliac arteries. Advantages to the use of the operating room 
included: (1) simultaneous angioplasty during a bypass operation for abnormalities 
proximal or distal to the graft, (2) correction of lesions first discovered uring 
th rombectomy, and (3) optimum patient monitoring and sedation in the operating room. 
Conclusions: Endovascular procedures performed by vascular surgeons in the operating 
room lead to results comparable with procedures performed in nonsurgical interven- 
tional suites, and the use of the operating room has advantages. (J Vasc Surg 
1996;24:353-62.) 
Depending on the medical community, patterns 
of referral, and experience, corrections of arterial or 
venous tenoses or occlusions by catheter techniques, 
angioplasty, thrombolysis, or stenting are performed 
by cardiologists, interventional radiologists, and vas- 
cular surgeons. Good published results have been 
presented by specialists in each of these fields. 
In contrast o several other reported series in 
which endovascular procedures by surgeons always 
involve open exposure of the artery or vein, in our 
community vascular surgeons perform both percuta- 
neous and open procedures. The purpose oft_his tudy 
is to compare the results of endovascular p ocedures 
performed exclusively by vascular surgeons in the 
operating room (OR) with a combined series from the 
literature, including percutaneous procedures per- 
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formed in radiology or cardiology facilities and some 
open endovascular p ocedures performed by vascular 
surgeons. For the purpose of this article, transluminal 
arterial or venous procedures are considered "closed" 
if percutaneous access was used, and "open" if a 
surgical incision was used to expose the access ite. 
MATERIALS AND METHODS 
We retrospectively reviewed all consecutive bal- 
loon angioplasty, catheter-directed thrombolysis, 
stent, and venous filter procedures for arteries and 
veins that were performed between 1990 and 1995 at 
Huntsville Hospital and Crestwood Hospital in 
Huntsville, Ma., by the three authors, who are all 
certified vascular surgeons. Only mesenteric and por- 
tal procedures were excluded. Procedures intended 
and initiated but not completed were methodically 
found and included. These latter cases were found not 
only by identifying Current Procedural Terminology 
(CPT) codes for endovascular therapeutic proce- 
dures, but also by searching for CPT codes that 
represent endovascular cannulation alone, and in- 
cluding these charts in our review. Ninety-eight 
percent of the procedures were performed in the OR 
and 2% (because of scheduling difficulties) by sur- 
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geons in a multipurpose cardiac and peripheral cath- 
eterization facility. Endovascular procedures repre- 
sent about 15% of our total vascular surgical opera- 
tions. 
Mobile C-arm imaging equipment, including 
Philips BV 29 release 2 (Philips Medical Systems, 
Eindhoven, Netherlands), and GE Stenoscop 
D6/D9 (General Electric Medical Systems, Milwau- 
kee) allowed three-axis rotation, digital images with 
averaging, subtraction, pulsed fluoroscopy, road- 
mapping, and images at peak opacification. Resolu- 
tion is between 525 and 576 lines per image. 
Individual cases ometimes necessitated ipsilateral 
or contralateral femoral, or upper extremity punc- 
tures, either proximally or distally directed. In various 
cases we used guiding catheters, size 0.018-inch 
through 0.035-inch ydrophilic wires, systemic hep- 
arin, regional heparin, aspirin, and monitoring of 
activated clotting time. Palmaz stents, Wallstents, and 
Gianturco-Roubin stents were used, but only for 
residual stenoses or important dissection after balloon 
angioplasty. The Wallstent was preferred for con- 
tralateral femoral approach, across joints, and in 
lengthy stented segments. Iliofemoral venous access 
always was attempted retrograde from the jugular 
vein, but it sometimes required puncture of the 
popliteal vein (n = 2). 
Pressure gradients across the lesion were mea- 
sured before and after most iliac dilations, but not 
usually for infrainguinal lesions. Most cases did not 
require powered injection and hand-injection suf- 
ficed, sometimes with custom-made, low-resistance, 
short, multihole catheters. Retrograde sheath injec- 
tion often worked well for lilac stenoses, with a total 
contrast dose <20 ml. Laser, intravascular ultrasound, 
and mechanical atherectomy have not been used, 
except for some early trial laser cases. Many occlusions 
responded to thrombolytic treatment, usually with 
catheter-directed infusion ofurokinase, often for 3 to 
48 hours, through standard coaxial arrangements, 
multihole catheters, or a single catheter embedded at
the top of the thrombus. 
Local anesthesia was sufficient for some cases, but 
epidural anesthesia was preferred for nonthrom- 
bolytic cases to improve patient comfort and thereby 
avoid needless premature termination of the more 
complicated procedures. In all but 10 cases, an 
anesthesiologist or anesthetist was present for the 
entire procedure. In three cases of epidural anes- 
thetic, thrombolytic nfusion treatment had not been 
anticipated and was performed at moderate dosage 
despite the epidural catheter, without complication, 
but the epidural hardware was not removed until 
after confirmation of nearly no;mal coagulation 
studies. 
Standard life table calculations were used to de- 
termine primary patency rates at 1-year of follow-up. 
Referral and follow-up patterns preclude reliable 
vascular surgical office records of long-term endovas- 
cular successes after the first year, so life table statistics 
were not carried past 1 year. At death, loss to 
follow-up, or failure of the treated segment, patients 
were censored from numbers at risk. Failure included 
occlusion, restenosis, need for a secondary procedure, 
and most amputations. Amputations caused by occlu- 
sion at a site distal to the treated segment, with known 
proximal patency, were not withdrawn. Redone pro- 
cedures were not reentered into the primary patency 
series. Technical failures were not counted again as 
complications. Endovascular management of a graft 
was included with the artery of the same level. Initial 
success was defined as (1) immediate technical result 
that converted stenosis or occlusion to stenosis <30%; 
(2) severe claudication, moderate claudication, rest 
pain, ulceration, or gangrene improved by one 
category; and (3) anlde/brachial index increased 
>0.10 in the absence of additional untreated lesions, 
or amplitude of pulse volume recording at least 
doubled in cases of falsely high ankle/brachial index. 
An independent registered nurse hired for this 
study retrospectively tabulated parameters of success 
at outpatient visits. Continued patency implied no 
deterioration i  the symptomatic category, no de- 
crease of more than 0.10 in the anlde/brachial index, 
no decrease in an improved pulse volume recording, 
or direct confirmation ofpatency by duplex imaging 
or arteriography. Tandem treated lesions required 
careful and fair decision in some cases, leaning against 
falsely missed recurrence. Amputation at any level, 
including the toe, was considered a failure of primary 
patency unless separate data, as detailed above, con- 
firmed patency. The patient's comfort level was evalu- 
ated by a questionnaire completed uring an inter- 
view with the nurse. 
To develop acontrol series of comparative current 
results for iliac and femoropopliteal segments, prima- 
rily in cardiology or radiology laboratories, everal 
MEDLARS searches of multiple combinations of 
subject headings were carried out to locate series 
published between 1992 and 1995 that included 
more than 10 patients and in which at least the 
immediate technical success rate was reported. All of 
the following types of studies were excluded: (1) 
review articles with no original data; (2) restatements 
of duplicate patients from other publications; (3) 
FDA trials; and (4) most papers that did not report 
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long-term results. Some papers about tests of new 
devices and papers that compared specific new varia- 
tions in tre.atment were included, but only the fraction 
of patients treated with generally accepted techniques 
were used. The combined series includes radiologic 
and cardiologic percutaneous procedures, but no 
operative percutaneous procedures, and is a suitable 
control group against ours. The series includes 
stenoses, occlusions, and stented cases. Because of the 
lack of open access in radiologic series, representative 
series that reported intraoperative r sults were in- 
cluded. Separate analysis, eliminating these surgical 
patients from the control group, does not alter the 
results in the control group. 
Series that calculated patency by first excluding 
technical lhilures were corrected by adding back these 
patients to adjust the initial number at risk and 
patency rate. When such technical failures were not 
even counted and listed, adjustment was made by the 
combined initial failure rate for the other control 
papers. Determination of the cumulative number of 
grafts that: were known to be patent or occluded at 1 
year for series that did not include a table of actual 
patients lost to follow-up in each time interval was 
calculated as "weighted n" in the table, which is the 
initial number in the series multiplied by the occlusion 
rate implied by the patency curve at 12 months, added 
to the number of patients at risk in the following 
interval. Combined series patency then was calculated 
as the tot~ number of patent grafts implied by adding 
the products of adjusted weighted n × patency and 
dividing by the sum of weighted n's. Some data were 
interpolated. Secondary patency rates for the com- 
bined series, often not reported, were not calculated. 
The results for the combined series were compared 
with those from our series with a ~2 test after multi- 
plying our primary patency or failure rate at 12 
months by the number of patients then at risk. 
Lower extremity arterial procedures were sepa- 
rated by arterial segment, including aorta, iliac artery, 
common femoral artery, superficial femoral artery, 
popliteal artery, or infrapopliteal arteries. Infra- 
popliteal vessels were defined as anterior tibial, pos- 
terior tibia], peroneal, dorsalis pedis, and tarsal 
branches, or grafts at these locations. Treatment of 
two separate segments at the same operation was 
tabulated as two separate procedures for immediate 
and long-term reporting. Common and external i iac 
arteries counted as one procedure, but superficial 
femoral and popliteal arteries were counted sepa- 
rately. Iliac arteries at their origin were not counted as 
an aortic procedure unless eparate higher dilation of 
the aorta was performed. Limb-threatening ischemia 
is defined as ischemic rest pain, ischemic ulceration, or 
gangrene. Patients who had a very low ankle/brachial 
index but none of the clinical indications listed above 
were not classified as having limb-threatening 
ischemia. 
RESULTS 
Six hundred seven procedures were completed in 
446 patients. Ninety-seven patients had Greenfield 
filters inserted. The method for inferior vena caval 
filter insertion was closed in 81 and open in 16, with 
the right jugular vein approach used in 84, and fight 
femoral vein access in 13. One carotid needle punc- 
ture had no adverse ffect. The most common reason 
for open placement was trouble encountered with 
expeditious percutaneous puncture in an anticoagu- 
lated patient. Open femoral access was used in two 
cases. In one patient who had right femoropopliteal 
venous thrombosis extending into the distal common 
femoral vein, transvenous subclavian pacing wire-de- 
pendence prevented safe jugular access. Open femoral 
exploration allowed us to positively stay above the 
common femoral vein thrombus. A similar approach 
was required for a similar venous thrombus in a case of 
coexisting infected subclavian central line. In two 
patients, filters were inadvertently deployed in the 
iliac vein. In both, a second filter was placed at a higher 
level, in the infrarenal inferior vena cava. In another 
patient who had pulmonary embolism and iliofemoral 
venous thrombosis, we bent a filter strut during 
successful venous thrombolysis, presumably penetrat- 
ing the cava, but no adverse vent was noted. 
As detailed in Table I, technical success was 
achieved in most cases of renal artery, aortic, upper 
extremity artery, upper extremity vein, and iliofemo- 
ral venous angioplasty orlysis. Three hundred twenty- 
five patients underwent 478 procedures for lower 
extremity arterial occlusive disease. One hundred 
ninety-one male patients (59%) and 134 female pa- 
tients had a mean age of 62 years (range, 30 to 94). 
Two hundred five patients had claudication (63%), 
and 120 had limb-threatening ischemia; 22% were 
diabetic. Of the 325 patients, 245 underwent a single 
procedure and 80 underwent additional procedures 
at the same time or at a separate time. The 80 patients 
with additional procedures included 124 procedures 
at additional sites (many bilateral iliac) and 29 sec- 
ondary procedures at the same site. A secondary 
procedure was classified as primary failure of the 
original procedure and was not included in 1-year 
primary patency calculations. For records that did not 
clearly state the location or length of the lesion, 
original arteriograms were reviewed. Infrapopliteal 
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Table I. Lower extremity arterial and other endovascular p ocedures 
Procedure Initial Stenosis/occlusion 
intended, Technical success~total indication for 
Procedure but not failure at procedures completed 
completed completed* completion intended procedures 
Open/pereutaneous 
technique for 
completed L ytic Rx Stent 
procedures used used 
Aorta 9 0 1 8/9 9/0 
Iliac artery 244 12 12 232/256 227/17 
Common femoral 3 0 0 3/3 3/0 
artery 
Superficial fern. 141 5 9 132/146 128/13 
artery 
Popliteal rtery 43 2 2 41/45 35/8 
Infrapopliteal ar- 38 5 4 34/43 31/7 
teries 
Upper extremity 13 0 2 11/13 9/4 
veins 
Upper extremity 8 1 0 8/9 8/0 
arteries 
Renal arteries 7 0 0 7/7 7/0 
IVC filter 97 2 0 97/99 -- 
Iliofemoral veins 4 0 0 4/4 0/4 
2/7 0 2 
83/161 9 33 
0/3 0 0 
38/103 11 11 
25/18 4 4 
14/24 7 5 
10/3 3 5 
4/4 0 0 
0/7 0 4 
16/81 - -  - -  
0 /4  4 3 
*Usually due to inability to traverse quidewire through lesion. 
procedures included anterior tibial (7), peroneal (6), 
posterior tibial (9), tibioperoneal trunk (9), and pedal 
arteries (6). Procedures on bypass grafts in 27 cases 
were classified by the artery at the equivalent level of 
the treated lesion. Many graft procedures involved 
angioplasty of an anastomotic or perianastomotic 
narrowing. Potency results were unchanged when 
bypass grafts were omitted. 
Patients were also classified according to the 
primary site that was originally treated, either aorta, 
iliac, or common femoral artery (AI), or infrainguinal 
(FPT) arteries. According to patients treated (rather 
than according to artery), the indication for interven- 
tion was limb-threatening ischemia in 28% of the AI 
group (51 of 180), and 51% of the FPT group (79 of 
155). Eleven percent of  the patients in the AI group 
had diabetes, compared with 35% of the patients in 
the FPT group. The mean age ofAI patients was 59.6 
years, compared with 64.8 years for FPT patients. 
When analyzed according to the procedures done, 
including additional procedures in the same patient, 
the indication for intervention was limb-threatening 
ischemia in 22% of AI procedures and 47% of FPT 
procedures (42% for femoropopliteal nd 69% for 
infrapopliteal). Balloon diameter was usually 6- to 
10-mm (especially 8-mm) for iliac artery, 3- to 8-ram 
(especially 5-mm) for femoropopliteal, and 2- to 
5-mm (especially 3-mm) for infrapopliteal arteries. 
Thirty-one procedures needed lytic therapy, and 55 
had one or more stents. The indication for placement 
of a stent in lower extremity arterial cases was arterial 
recoil in 46 procedures, unacceptably irregular dis- 
section in six, and recurrent stenosis in three. Primary 
stenting was never performed for successful first 
balloon angioplasty of a lesion. In addition to the 
above procedures, 24 procedures were intended, but 
never completed, usually as a result of failure of 
guidewire traversal. Many were converted to open 
bypass. 
Complications within 30 days included groin 
hematoma or pseudoaneurysm in 14 M patients and 
three FPT patients (15 unoperated, two surgically 
corrected), distal embolization i  three M patients, 
contralateral embolization i  one M patient and in 
one FPT patient, acute thrombosis at the treated site 
requiring open operation in one M patient and one 
FPT patient, occlusion of the contralateral iliac artery 
in a contralateral approach in two FPT patients, 
nonfatal myocardial infarction in three M patients, 
infection at the access ite in two M patients, and one 
case of diffuse femoropopliteal vein graft spasm in 
popliteal angioplasty via the graft, resolved spontane- 
ously after 4 days of anticoagulation. Eight proce- 
dures resulted in restenosis; all required a bypass 
operation during the same admission, including five 
infrainguinal bypasses and two aortofemoral or il- 
iofemoral operations. 
Five of 325 patients died within 30 days (three 
in the M group, two in the FPT group), but four 
of these patients had additional bypass urgery in that 
time. Deaths included two patients with metastatic 
cancer, two myocardial infarctions (one occurred 7 
days before endovascular intervention, the other 3 
weeks later during resumption of jogging), and one 
patient who had septic shock. In two cases, com- 
plications occurred uring stent deployment, both in 
JOURNAL OF VASCULAR SURGERY 
Volume 24, Number 3 Gross, Johnson, and Roberts 357 
the iliac artery. In one, the stent was dislodged from 
the percutaneous balloon, coming to lie freely in the 
iliac artery, but it was retrieved on open femoral 
exploration. In another, a thin balloon engaged the 
strut of a Palmaz stent during open iliac angio- 
plasty with femoropopliteal bypass. As a last step 
before directly exploring the iliac artery, the stent 
was forcefully extracted with the balloon, which 
resulted in an endarterectomy of the external iliac 
artery, with an acceptable result, that was patent at 
2 years of follow-up. 
For 38 completed infrapopliteal angioplasties, 
four complications occurred in 30 days. A stenotic, 
calcific peroneal artery that was treated by angioplasty 
with a 2.5-mm balloon at high inflation pressures 
caused extravasation and later occlusion, but no 
hematoma developed. In this case, concomitant pos- 
terior tibial-origin angioplasty sufficed to cause heal- 
ing of the ischemic ulcer. A second infrapopliteal case 
had healing of a toe amputation, but prolonged 
hospitalization from cardiac arrhythmias and non-q- 
wave myocardial infarction, from which he recovered. 
A third patient who had extensive distal dissection of 
a diffusely diseased peroneal artery needed amputa- 
tion, because femoral-pedal rtery bypass was impos- 
sible as a result of diffuse beaded stenoses of posterior 
tibial, dorsalis pedis, and tarsal arteries. A fourth 
patient sustained eep venous thrombosis, which 
improved after anticoagulation. 
Of the 160 open procedures, 105 required an 
open approach because a concomitant open vascular 
procedure was being performed. Of these, 56 were 
iliac angioplasties performed during femoropop- 
liteal/tibial bypass. Thirty-one were femoropopliteal 
angioplasties performed to improve runoff during 
aortofemoral or femorofemoral artery bypass or revi- 
sion. Five were aortoiliac or iliac angioplasties per- 
formed because of the discovery of a severe iliac artery 
stenosis as the causative lesion during transfemoral 
lilac thrombectomy. Four were infrainguinal angio- 
plasties that were performed as a result of the discov- 
ery of a causative superficial femoral, popliteal, or 
tibial stenosis during transfemoral thrombectomy for 
distal thrombosis. Seven cases were transluminal cor- 
rections of a distal anastomotic or native arterial 
stenosis during segmental replacement or patch of a 
vein graft stenosis. One open case involved translu- 
minal stenting of one limb of an 8-year-old aorto- 
femoral graft after thrombectomy uncovered chronic 
excessive: graft lengthening, with angulation and ldnk. 
In one case, clamp injury of an iliac artery during 
repair of an abdominal aortic aneurysm was immedi- 
ately corrected by open, transfemoral, transluminal 
angioplasty, avoiding conversion to an aortofemoral 
graft, then with continued patency at 2 years. Fifty- 
five of 160 open procedures involved difficulty in 
percutaneous access. Twenty-two were planned be- 
cause of worrisome, known, high anastomosis of a 
previous aphenous vein, polytetrafluoroethylene, or 
umbilical vein graft at the groin. Four procedures had 
a known pseudoaneurysm of aprevious aortofemoral 
graft, which prevented safe percutaneous cannula- 
tion. In 29 procedures percutaneous access was at- 
tempted but was unsuccessful. Although we routinely 
perform high, antegrade cannulation of the common 
femoral artery with guidance of a wire into the 
superficial femoral artery, sometimes this technique 
cannot be used, which accounts for some of these 
conversions to open angioplasty. Others involve se- 
verely scarred groins caused by earlier procedures. In 
three cases, dense scar prevented sheath insertion, 
despite needle and guidewire ntry. 
Because of the difficulty in correlating hospital 
charges with actual medical resource use, we looked 
instead at length of stay (LOS). LOS was 4.5 +_ 3.7 
days for AI patients (median, 3 days; n = 166) and 
6.1 + 8.3 days for FPT patients (median, 3 days; 
n = 140), significant to p < 0.03. The most important 
risk factor for increased LOS is limb-threatening 
ischemia, with nondiabetic LOS of 4.1 + 3.9 days 
(n = 134) in claudication, and 6.6 _+ 4.3 days (n = 71 ) 
in limb-threatening ischemia (p = 0.00004), when 
compared with diabetic LOS of 4.0 +_4.7 days 
(n = 40) in claudication, and 6.3 +_ 5.3 days (n = 35) 
in limb-threatening ischemia (p = 0.05). Open angio- 
plasty often included proximal or distal bypass, so an 
LOS of 7.22 days for open iliac angioplasty exceeded 
the 2.97-day LOS for closed iliac angioplasty. This 
latter LOS difference was not observed in FPT 
patients. 
Thrombolytic infusion successfully recanalized 
seven of nine occluded lilac arteries, all of which 
required subsequent angioplasty, stents, or both. For 
infrainguinal rteries, thrombolytic recanalization c- 
curred in 12 of 15 femoropopliteal arteries. One failed 
femoropopliteal thrombolysis patient had a history of 
repeated arterial thromboses and was diagnosed with 
a dysplasminogenemia. Of twelve femoropopliteal 
thrombolytic recanalizations, eleven arteries were 
treated with angioplasty after thrombolysis, but one 
did not require further treatment. The latter case was 
in a patient who had popliteal arterial occlusion after 
blunt trauma to the popliteal space with no orthope- 
dic injury, and had a normal appearance after lysis of 
a 6-cm thrombus. 
Early hemodynamic data are shown in Table II. 
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Table II. Lower extremity arterial endovascniar p ocedures, Doppler results 
Preop ABI (mean + 1 SD), n Postop ABI (mean +1 SD), n p (Student's t test ) 
Aorta 0.65 + 0.36, 12 1.06 + 0.19, 12 p < 0.01 
Iliac artery 0.61 + 0.24, 136 1.02 + 0.18, 178 p < 0.001 
Common femoral rtery -- -- -- 
Superficial femoral rtery 0.545 + 0.26, 83 1.04 + 0.17, 92 p < 0.001 
Popliteal rtery 0.48 + 0.20, 17 0.965 + 0.21, 19 p < 0.001 
Infrapopliteal arteries -- -- -- 
Primary patency rates, reported in Tables III and IV, 
were determined at1 year. As a result of the resump- 
tion of follow-up by the primary care physician for 
successful cases, valid data were not available to 
determine patency reliably after 1 year. Secondary 
patency rates are not useful in this series because most 
symptomatic failures are treated with bypass urgery. 
Long-term life table results for iliac arteries begin with 
256 procedures minus eight secondary procedures, 
for 248 arteries observed. Thirty-six were immediate 
or 30-day failures, for an 8 5.5% success rate at 3 0 days. 
During the subsequent year, one patient died, one was 
lost to follow-up, and 52 had uncertain follow-up 
information (though many were suspected patent) or 
did not reach 12 months' follow-up, for calculated 
withdrawal of 54 arteries. During that time, three 
were hemodynamic failures, and one had amputation 
because of iliac restenosis, for a total of four failures 
and an interval failure rate of 2.2%. For the 180 AI 
patients, two above-knee amputations, no below- 
knee amputations, no transmetatarsal amputations, 
and four toe amputations were performed in the first 
year. The cumulative 12-month patency rate is calcu- 
lated at 83.7% (n - 194 followed to i year). Results of 
the control series and the current series fo rm patients 
are reported in Table III. The 1-year patency rate is 
statistically no different from that of the control series 
(84.3%). We used stents less frequently (13.5% of 
arteries) and had a lower failure rate for guidewire 
traversal (4.7%), a lower complication rate (8.2%), but 
an equivalent rate of technical success. 
Life table data for superficial femoral and 
popliteal lesions begins with 191 treated arteries 
minus 29 secondary procedures, leaving 162 to 
follow-up. Eighteen procedures were technical fail- 
ures, which resulted in a first-day failure rate of 
11.1%, and 144 procedures left for follow-up. For 
155 FPT patients, 14 toe amputations, three trans- 
metatarsal mputations, even below-knee and two 
above-knee amputations were performed uring the 
first year. During the first year, three arteries res- 
tenosed, one required later thrombectomy, and two 
required more aggressive dilation with a larger bal- 
loon for hemodynamic failure. There were 16 late 
hemodynamic failures, three amputations without 
proven patency, three deaths, 11 patients lost to 
follow-up, and 35 patients with outpatient data in- 
adequate to evaluate patency or who had not yet 
reached 12 months. In the 1-day to 12-month in- 
terval, there were thus 25 failures and 49 withdraw- 
als, for an interval failure rate of 20.9%, and a 1-year 
patency rate of 70.3% (I13 patients followed-up to 
1 year). This 1-year patency rate was significantly 
better than the patency rate of 56.2% for the control 
series (p < 0.0i; Table IV). The immediate technical 
success rate of 90.6% was not significantly better than 
that of the control series. 
In more than 50% of cases, interventions by 
anesthesia staff were found that are not usually 
performed in a typical dedicated angiography suite, 
including continuous monitoring of blood pressure 
and other hemodynamic parameters, with adjust- 
ments of fluid status, management of hyperglycemia, 
and monitoring of O2/CO 2 level leading to respira- 
tory assistance. In many cases adequate patient com- 
fort required substantial narcotic doses and then 
temporary mask ventilation or reversal of drugs; this 
requirement allowed completion of a complicated 
procedure without premature termination. In at least 
10 cases temporary endotracheal intubation was per- 
formed during sedation. Reactions to analgesic and 
sedative medicines, as well as cardiac arrhythmias, 
were promptly handled. In all cases, including both 
percutaneous and open access, the sterility of angio- 
plasty balloons, catheters, and stents was optimized by 
the use of masks by all personnel, air filtration, and 
daily cleansing of operating rooms according to the 
standards of the Joint Commission on Accreditation 
of Hospitals. 
Comfort level was surveyed in 63 patients. For 
patients who underwent both preoperative diagnostic 
arteriography in the radiology suite and intervention 
in the OR, the opinion of the patient or family 
members universally demonstrated less discomfort 
with therapeutic than diagnostic procedures, despite 
the greater complexity and time required for thera- 
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Table III. Iliac artery endovascular p ocedures 
Primary 
Failure of Immediate patency 
guidewire technical Complication at 1 yr 
Publication n traversal success rate (%) 
Adjusted Number of 
Weighted patency Adjusted stented 
n (%) weight arteries 
Williams ('94) 1 104 10/104 84/94 12/94 - -  
Jorgensen ('92) 2 174 12/174 162/174 31/174 81 
Blum ('93) 3 47 1/47 46/47 7/47 95.7 
Vorwerk ('92) 4 125 22/125 103/125 5/125 94.6 
DeMasi ('94) s 11 0/11 11/11 3/11 100 
Lorenzi ( '94) 6 268 21/267 246/267 27/268 85.1 
Bull ('93) 7 46 - -  46/46 5/46 77 
Hsiang ('93) 8 37 - -  35.6/37 7.1/37 90 
Wolf ('93) 9 81 - -  75/81 - -  73.8 
Nine series com- 893 66/728 809/882 97.1/802 
bined (9%) (91.7%) (12%) 
Present series 256 12/256 232/256 21/256 83.7 
(4.7%) (90.6%) (8.2%) 
~2, combined vs p = 0.04 p = 0.67 p = 0.1 
present series 
- -  - -  - -  94/94 
124 81 124 0/174 
37 93.7 38 18/47 
86 94.6 86 85/85 
2 100 2 13/13 
227 85.1 227 22/268 
36 77 36 0/46 
10 90 10 - -  
74 73.8 74 - -  
84.3 597 232/727 
(32%) 
194 83.7 194 33/244 
(13.5%) 
p=0.8 
Table 1N'. Femoropopliteal arterial endovascular p ocedures 
Publication n 
Primary 
Failure of Immediate patency 
guidewire technical Complication at I yr 
traversal success rate (%) 
Adjusted Number of 
Weighted patency Adjusted stented 
n (%) weight arteries 
Matsi ('94:) 1° 140 184/208 6/168 47 
Becquemin ('94) 11 103 14/103 81/103 7/103 60 
Ashleigh ('94) 12 123 9/123 93/103 7/123 - -  
Hunink ('93) 13 131 - -  125/131 12/126 57 
E1-Bayar ('92) 14 27 - -  18/27 3/27 90 
Currie ('94) ls 51 - -  40/51 10/51 42 
Gordon ('94) 16 57 - -  42/57 - -  29 
Jeans ( '94y  137 14/137 107/137 - -  59.6 
Murray ('95) is 44 2/44 41/44 5/44 85.9 
Vroegindeweij ('95) 19 35 0/35 35/35 1/35 71 
White ( '95) 20 32 0/32 32/32 2/32 83 
Do ('94) 21 160 - -  - -  - -  69 
Hsiang ('93) 8 51 - -  48/51 8/51 84.5 
Wolf ('93) 9 49 - -  - -  - -  59 
Fourteen series 1,040 39/474 846/979 61/760 
combined (8.2%) (86.4%) (8%) 
Present series 191 7/191 173/191 9/191 70.3 
(3.7%) (90.6%) (4.7%) 
~2, combined vs p = 0.05 p = 0.15 p = 0.16 
present series 
126.5 42 143 2 
68.7 60 68.7 0 
105 57 105 0 
18 59 27 0 
46.6 42 46.6 - -  
57 29 57 0 
133 59.6 133 0 
37 85.9 37 0 
25 71 25 0 
28 83 28 31 
112 59 112 - -  
23 84.5 23 0 
49 59 49 0 
56.2 854 33/1040 
(3.2%) 
113 70.3 113 15/184 
(8.2%) 
p<0.01 
peut ic  operat ions.  Anesthet ic  services were not  rou-  
t inely available dur ing  d iagnost ic  angiography,  but  are 
always used dur ing  angioplasty. 
D ISCUSSION 
This  series reports  a large cohor t  o f  pat ients 
t reated by vascular surgeons where  endovascular  pro-  
cedures are rout ine ly  per fo rmed in the OR.  Advan-  
tages o f  management  by the vascular surgeon in the 
OR inc luded the efficient cor rect ion  o f  many  lesions 
that  were ev ident  at open  operat ion  and were best 
repaired at that  t ime. In  addit ion,  we avo ided the 
infect ious risk o fa  percutaneous  procedure  at the site 
o f  insert ion o f  a prosthet ic  graft soon thereafter  and 
obta ined  the addit ional  benef i t  o f  s imul taneous in- 
f low and out f low repair, wh ich  is known to improve  
the patency o f  each site. 22,23 For  safe mon i to r ing  and 
t reatment ,  anesthesiologists at our  inst i tut ion prefer 
the use o f  the OR to the rad io logy laborator ies for 
per fo rming  endovascular  procedures.  Also,  the ste- 
rility that  is requ i red  when the procedure  is con-  
ver ted  to an open  operat ion  is not  possible in most  
rad io logy or  card io logy suites, a l though at some 
centers substantial  capital investment  has a l lowed 
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dual endovascular/OR procedure rooms outside of 
the main OR complex. 
Our 3-day hospital LOS for many percutaneous 
patients, due to separate diagnostic angiograms and 
endovascular procedures, can and will be reduced. 
On the other hand, it is likely that hospital stay for the 
176 open procedures was lower than expected, either 
by avoiding a second day for converting percutaneous 
to open approach or by combining the endovascular 
step with the bypass or endarterectomy. Even when 
diagnostic and therapeutic endovascular interven- 
tions are combined into one event, the facility and 
personnel time that is conserved is often not evident 
because of a second direction or site of puncture and 
an additional contrast dose. Discussion with and 
permission from the patient and the family can be 
difficult when diagnostic study includes intervention. 
Evolving technologies, uch as duplex ultrasound or 
magnetic resonance angiography, may permit elimi- 
nation of diagnostic angiographic imaging in the 
hospital for many patients. 24,25 
Our results compare favorably with published lilac 
and femoropopliteal series. The data from the control 
groups may not be entirely comparable with the data 
in our series, partly because of differences in severity of 
ischemia and acuity, which are often difficult to 
quantitate for the publications used as our control 
group. Radiologic or cardiologic technical success 
for the dilation of aorta, renal, and infrapopliteal 
arteries, implantation of IVC filters, and lysis/angio- 
plasty/stenting of iliofemoral venous thrombosis all 
exceed 90%, and our success compares favorably with 
that of these groups as well. This series demonstrates 
that endovascular techniques can be an important 
component ofintraoperative treatment of peripheral 
vascular disease by vascular surgeons. 
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D ISCUSSION 
Dr. Daniel F. Fisher (Chattanooga, Tenn.). When I 
was asked to discuss this paper, I quicldy admitted that I had 
no personal experience dilating arteries and no personal 
experience placing stents into arteries after dilation. At 
Erlanger Medical Center in Chattanooga all of this work is 
done by a talented group ofinterventional r diologists, but 
fortunately we get the opportunity to evaluate most of these 
patients before they perform these procedures. I realize that 
I 'm preaching to the choir, but most radiologists and 
cardiologists have very little or no understanding about he 
pathophysiologic mechanisms of and the indications for 
these procedures. Radiologists and cardiologists see arterial 
stenoses purely as a technical exercise. They put in a guide 
wire, they dilate the artery, they insert a stent, and then they 
forget about he patient. Virtually no meaningful follow-up 
is reported in the radiology or the cardiology literature. 
This presentation on endovascular p ocedures i very 
unusual, and I think that patients in the Huntsville, Ala., 
area are the direct beneficiaries. First of all, all of these 
procedures were performed in the OR by a talented group 
of three surgeons who clearly have more patience with 
catheters than most of us. Second, strict preoperative 
indications were followed. Third, pressure gradients were 
measured in all of the larger arteries to ensure real results. 
Fourth, the anesthesiologists were involved with all cases to 
assure patient comfort and optimum cardiorespiratory 
monitoring. And fifth, I year of follow-up was presented for 
all patients, which by itself makes this paper distinctive in 
contrast to those published by the typical radiologist. 
Dr. Gross, you mentioned that 27 procedures were 
attempted, but never completed because 9f the failure to 
pass a guide wire through an obstructing lesion. In retro- 
spect, do you believe that you wasted your time at even 
attempting todilate these arteries, which certainly represent 
the toughest case for this technology? As all of us move into 
the area of managed care, will you be able to justify the 
additional time in the OR and expense of this technology to 
your referring physicians and medical care organizations? 
For those of you who are interested in reading asuperb 
critique of this subject, I would refer you to Dr. John M. 
Porter's editorial in the June 1995 issue of the Journal of 
Vascular Surgery (J Vase Surg 1995;21:995-7). Dr. Porter, 
in his eloquent way, points out that we have no substantive 
cohort data that objectively establish the role of interven- 
tional the, rapy in any area of arterial or venous disease. 
Anecdotes abound, and hard data are scarce. Dr. Porter 
points out that in the past three decades the Vineberg 
procedure, chelation therapy, gastric freezing, carotid body 
excision, extracranial-intracranial bypass, and laser angio- 
plasty have all been procedures that had initial enthusiasm 
but fell out of favor when proponents failed to prove 
efficacy. 
The important questions are: (1) how often do thcse 
procedures succeed; (2) how often do they cause 
complications; (3) what is the relative cost; and (4) what is 
thcir overall therapeutic value in comparison with well- 
performed vascular surgical procedures. The individual who 
proposes omething new clearly has the burden of proof to 
establish beyond a reasonable doubt that cndovascular 
arterial intervention is as good as traditional vascular 
surgery. 
Dr. Gary M. Gross. Regarding thc 27 attempts that 
were not completed, all cndovascular series have initial 
failures. They are oftcn hidden in the data or not reported, 
but we tried to honestly and openly report hem. Many were 
occluded arteries. We initially do not know whether they are 
completely filled with plaque and calcification with an 
inaccessible umen or whether they are partly thrombus. 
Testing with a guidewire is useful information in determin- 
ing whether the lesion can potentially be opened with 
balloon dilatation or lyric therapy. Failure in our intention to 
perform an endovascular p occdure isa successful diagnos- 
tic step in the decision to move on to a different treatment, 
which was often an immediate bypass operation at that time. 
In some circumstances, uch as in very obese patients, 
failure of percutaneous access did not cause failure of the 
endovascular p ocedure because we were able to immedi- 
ately convert o safe, open, endovascular ccess in a sterile 
OIL 
In answer to the managed care setting and the justifi- 
cation of procedure time and expense, our length of stay was 
reasonable. In many patients we are now eliminating the 
postoperative observation day. For many cases we thought 
we reduced the cost of care by performing the endovascular 
step during the open procedure, such as repair of the 
causative stenotic lesion during arterial thrombectomy. I 
don't know that the operating room is necessarily more 
expensive than other hospital procedure suites. Hospital 
charges are often higher, but actual hospital resources 
expended are not higher. Despite the stated hourly hospital 
OR charge, the resources used per procedure for regular 
endovascular operations inan OR, including the number of 
nursing personnel, are considerably lower than, for ex- 
ample, an open aneurysm repair in that same OR. 
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Dr. Ali AbuRahma (Charleston, WVa). I admire the 
presentation of such extensive experience in terms of 
angioplasty. I perform roughly half, or maybe closer to a 
third, of the endovascular p ocedures in our institution; the 
other two thirds are performed by two radiologists and one 
cardiologist. But I am confining myself to what is approved 
by the FDA: iliac stenting and, of course, various balloon 
angioplasties plus filters. Because you have performed so 
many of the stenting procedures outside the territory of the 
iliac artery, which is primarily Palmaz and of course Wall- 
stent, are you following certain institutional review board 
protocols? Are you explaining to these people that the 
procedures are not being accepted still by the government 
in these situations? 
Secondly, only one specific polyethylene balloon by 
Meditech is approved for iliac angioplasty with a stent. The 
sheaths for these are 8F to 10F. If done percutaneously, 
that's a big hole. Are you modifying it like some of my 
cardiologists who are doing it using other balloons? And if 
you are, are you again explaining to the patient hat the 
government did not approve that stent on that balloon? 
I originally did not want to ask this question, but I heard 
you talk about the expenses. We made a deal with our 
hospital administration about needing a special type of 
arrangement in terms of expenses where we make the 
operating room cost equivalent to the cardiac atheteriza- 
tion facility and the radiology suite. It worked out very well 
with us, so whenever we perform an angioplasty he cost has 
been modified to be comparable to the cost of whatever it
costs in the cardiac atheterization facility. 
Dr. Gross. We only use stents approved by the FDA. In 
obtaining consent, I frequently tell the patient's family that 
the FDA does not prohibit additional device applications 
chosen by the physician for an individual patient, but 
current FDA regulations may not have yet extended ap- 
proval for the company or physician to promote the product 
for the specific artery to be treated. Then I quote the known 
reported experience in these other locations, so the patient 
knows these issues. I now seldom use stents premounted on 
balloons, but prefer myself to mount the best stent for that 
lesion on the best balloon for that lesion. These products are 
changing nearly every week. The thinner balloons are 
becoming stronger, so we can often use a smaller or more 
compliant balloon, and a smaller sheath or catheter. 
Regarding expense accounting, in the future, when 
physician-led independent practice associations or health 
maintenance organizations bargain with hospitals for deter- 
mining reimbursement, a single price for OR setup and time 
must be replaced by a price related to resource use, which is 
lower for endovascular than for other vascular procedures. 
Your formula to compare with a cardiology or radiology 
laboratory is an appropriate and good idea. 
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